CRP and chronic kidney disease: Performing the subgroup analysis showed that the pooling of the results of the studies that were conducted in the United States, contrary to the result of studies that were conducted in countries other than the USA, led to a finding of a significant decrease in the levels of C-reactive protein in CKD patients (p < 0.001, p = 0.77, respectively).